Vuzix partners with Shiny Box Interactive on military medical training for Ultralite Pro smart glasses
Bitget2026/10/06 13:15Vuzix partnered with Shiny Box Interactive to develop military medical training and remote-mentoring solutions on the Ultralite Pro OEM smart glasses platform. Collaboration shifts Shiny Box’s defense-focused AR training work from earlier Vuzix devices to Ultralite Pro’s lightweight, see-through waveguide design. Platform targets hands-free remote mentoring across satellite, cellular, LAN, and mobile ad hoc networks for field medical support in austere environments. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vuzix Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610060915PR_NEWS_USPR_____NY64530) on October 06, 2026, and is solely responsible for the information contained therein.
- Vuzix partnered with Shiny Box Interactive to develop military medical training and remote-mentoring solutions on the Ultralite Pro OEM smart glasses platform.
- Collaboration shifts Shiny Box’s defense-focused AR training work from earlier Vuzix devices to Ultralite Pro’s lightweight, see-through waveguide design.
- Platform targets hands-free remote mentoring across satellite, cellular, LAN, and mobile ad hoc networks for field medical support in austere environments.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.